Details of the Drug
General Information of Drug (ID: DMTFBCU)
Drug Name |
7-Methoxy-1H-indazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
7-methoxy-1H-indazole; 133841-05-1; 1H-Indazole, 7-methoxy-; CHEMBL15921; ACMC-20aa2r; 7-METHOXYINDAZOLE; SCHEMBL5483794; SCHEMBL18003573; CTK0H0012; KS-00000DHI; DTXSID90439880; QCBANHQTMCETBI-UHFFFAOYSA-N; MolPort-009-199-308; BDBM50099399; ANW-63985; ZINC26894532; AKOS024124789; AKOS006290288; TRA0059918; AS-8550; RP01575; PB32675; RTC-062053; AN-6943; KB-46446; AC-29510; SY032798; SC-54780; AK-58155; AJ-82859; 1429222-35-4; TC-062053; DB-062996; Y7436; ST24045679; FT-0767863; 4CH-023995; CS-0043993; AM20020408; MFCD08752584 (97%); Q-2252
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 148.16 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||